Insmed Incorporated (INSM) earnings
INSM earnings moved a median of -0.38% by the close. Quarterly and annual INSM reports and results, each read against the price at its own news timestamp. Back to the INSM overview →
29 measured INSM earnings events.
Where these INSM earnings landedvs 29 measured INSM earnings reactions
| Middle 50% of INSM earnings reactions | -2.38% to +4.01% |
|---|---|
| Median reaction (to close) | -0.38% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 INSM earnings events with a measured close landed between -2.38% and +4.01%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q INSMED Inc For: Jun 30 | SEC filing · Form 10-Q | +3.09% | +4.37% | |
| Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update | Press release | +3.09% | +4.37% | |
| Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026 | Press release | +0.45% | +1.52% | |
| Form 10-Q INSMED Inc For: Mar 31 | SEC filing · Form 10-Q | +5.59% | -10.19% | |
| Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update | Press release | +5.59% | -10.19% | |
| Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 | Press release | +0.29% | -0.45% | |
| Form 10-K INSMED Inc For: Dec 31 | SEC filing · Form 10-K | -3.75% | +4.70% | |
| Form 10-Q INSMED Inc For: Sep 30 | SEC filing · Form 10-Q | +5.21% | +13.41% | |
| Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update | Press release | +5.21% | +13.41% | |
| Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 | Press release | +0.53% | +0.83% | |
| Form 10-Q INSMED Inc For: Jun 30 | SEC filing · Form 10-Q | +4.42% | +2.58% | |
| Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update | Press release | +4.42% | +2.58% | |
| Insmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025 | Press release | +0.41% | -0.38% | |
| Form 10-Q INSMED Inc For: Mar 31 | SEC filing · Form 10-Q | +0.15% | -3.34% | |
| Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update | Press release | +0.15% | -3.34% | |
| Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 | Press release | -0.34% | -2.38% | |
| Form 10-K INSMED Inc For: Dec 31 | SEC filing · Form 10-K | +3.88% | +4.51% | |
| Form 10-Q INSMED Inc For: Sep 30 | SEC filing · Form 10-Q | -0.42% | -1.91% | |
| Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update | Press release | -0.42% | -1.91% | |
| Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 | Press release | -0.41% | -2.93% | |
| Form 10-Q INSMED Inc For: Jun 30 | SEC filing · Form 10-Q | +4.48% | +4.01% | |
| Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update | Press release | +4.48% | +4.01% | |
| Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024 | Press release | -0.01% | -0.59% | |
| Form 10-Q INSMED Inc For: Mar 31 | SEC filing · Form 10-Q | -9.40% | -6.82% | |
| Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update | Press release | -9.40% | -6.82% | |
| Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 | Press release | -0.91% | -1.81% | |
| Form 10-K INSMED Inc For: Dec 31 | SEC filing · Form 10-K | -6.39% | -1.63% | |
| Form 10-Q INSMED Inc For: Sep 30 | SEC filing · Form 10-Q | -0.43% | +0.23% | |
| Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update | Press release | -0.43% | +0.23% |
Keep exploring
More INSM: analyst actions → · SEC filings → · INSM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Synthetic Biologics, Inc. (SYN) | 703 | -0.34% | 41% |
| PishPosh, Inc. (BABY) | 702 | 0.00% | 48% |
| Revance Therapeutics, Inc. (RVNC) | 701 | 0.00% | 42% |
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.